Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 31,358 shares at $3.63 ($114K) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Seasonal sale ($114k) by President and CEO — this insider has traded ATRA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.63 | 15,679 | $57K | 50.0% |
| 2 | $3.63 | 15,679 | $57K | 50.0% |
| Total | $3.63 avg | 31,358 | $114K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |